However, the sensitivity of PDAC cell lines is lower than that of NSCLC cell lines, which implies that other molecular mechanisms besides MYC regulation might play a key role in mediating the anti-tumorigenic effect of BET inhibition. This evidence concerns the gene DNER and non-small cell lung carcinoma.